Lapointe NP, Guertin PA. Synergistic effects of D 1/5 and 5-HT 1A/7 receptor agonists on locomotor movement induction in complete spinal cord-transected mice. J Neurophysiol 100: 160 -168, 2008. First published May 14, 2008 doi:10.1152/jn.90339.2008. Monoamines are well known to modulate locomotion in several vertebrate species. Coapplication of dopamine (DA) and serotonin (5-HT) has also been shown to potently induce fictive locomotor rhythms in isolated spinal cord preparations. However, a synergistic contribution of these monoamines to locomotor rhythmogenesis in vivo has never been examined. Here, we characterized the effects induced by selective DA and 5-HT receptor agonists on hindlimb movement induction in completely spinal cord transected (adult) mice. Administration of the lowest effective doses of SKF-81297 (D 1/5 agonist, 1-2 mg/kg, ip) or 8-OH-DPAT (5-HT 1A/7 agonist, 0.5 mg/kg, ip) acutely elicited some locomotor-like movements (LM) (5.85 Ϯ 1.22 and 3.67 Ϯ 1.44 LM/min, respectively). Coadministration of the same doses of SKF-81297 and 8-OH-DPAT led to a significant increase (7-to 10-fold) of LM (37.70 Ϯ 5.01 LM/min). Weight-bearing and plantar foot placement capabilities were also found with the combination treatment only (i.e., with no assistance or other forms of stimulation). These results clearly show that D 1/5 and 5-HT 1A/7 receptor agonists can synergistically activate spinal locomotor networks and thus generate powerful basic stepping movements in complete paraplegic animals. Although previous work from this laboratory has reported the partial rhythmogenic potential of monoamines in vivo, the present study shows that drug combinations such as SKF-81297 and 8-OH-DPAT can elicit weight-bearing stepping.
I N T R O D U C T I O N
The existence of a neuronal network capable of generating the basic commands for walking has been clearly demonstrated several years ago in completely spinal cord-transected cats (preliminary evidence reported by Brown 1911; Grillner and Zangger 1979) . Often referred to as the central pattern generator (CPG), this network-located for the most part in the lumbar spinal cord-was reported indeed to produce locomotor-like activity following systemic administration of levodopa (L-DOPA; L-3,4-dihydroxyphenylalanine) and nialamide (noradrenergic/dopaminergic precursor and monoamine oxidase inhibitor, respectively) in the complete absence of input from the brain and the periphery (low-thoracic-transected and rhizotomized cats; Grillner and Zangger 1979) . Shortly after that discovery, a plethora of substances tested in acute or chronic paraplegic cats have provided data suggesting that several monoaminergic systems are involved in the control of locomotion (reviewed in Rossignol et al. 2001) . Along this line of evidence, a role for monoaminergic neurotransmitters in locomotor functions was strongly supported by Gerin et al. (1995) who showed, using spinal cord-implanted microdialysis probes and chromatography, an increase of dopamine (DA) and serotonin (5-HT) release in the ventral funiculus (lumbar segments) of animals running on a motor-driven treadmill.
In the 1990s, compelling evidence mainly from in vitro isolated spinal cord preparations has suggested that synergistic actions on CPG neurons can be achieved by coactivating different families of transmembranal receptors. For instance, bath-applied 5-HT, DA, and/or N-methyl-D-aspartate (NMDA) were reported to potently induce stable fictive locomotor rhythms in in vitro isolated spinal cord preparations (rats: Cazalets et al. 1992; Kiehn and Kjaerulff 1996; Kjaerulff et al. 1994; mice: Jiang et al. 1999; Whelan et al. 2000; lampreys: Zhang and Grillner 2000) .
Some of these results were recently confirmed in vivo using spinal cord-transected (Tx) models. For instance, quipazine (5-HT 2 agonist) and L-DOPA were found to generate greater effects on hindlimb movement induction when coadministered in Tx rats (McEwen et al. 1997 ) and mice (Guertin 2004a; Landry and Guertin 2004) . Quipazine-induced air-stepping was found to critically depend on glutamate receptor activation (i.e., endogenous glutamate release since blocked by in Tx mice (Guertin 2004b) . D 1/5 (D 1-like ) receptor agonists (but not D 2-like or D 2/3/4 agonists) were shown to specifically induce locomotor-like movements (LMs) in complete paraplegic mice (Lapointe and Guertin 2005; unpublished data) . Most recently, 5-HT 1A/7 ligands and 5-HT 7 knockout (5-HT 7 Ϫ/Ϫ ) mice were used to demonstrate a specific role in LM induction for both receptor subtypes (i.e., 5-HT 1A and 5-HT 7 ) in Tx animals (Landry et al. 2006a ). However, it remains unclear whether simultaneously activating some of these specific receptor subtypes in vivo may lead to synergistic actions on CPG activation and hindlimb movement induction. Given that 5-HT 1A/7 and D 1/5 receptor agonists tested separately were found recently, in both in vitro and in vivo experiments, to display potent CPG-activating effects, we decided to assess their effects as a combination treatment on hindlimb movement generation in Tx mice.
The present series of experiments aimed at determining in vivo whether D 1-like and 5-HT 1A/7 receptors may synergistically induce stepping. Drug-induced movements were assessed in complete Tx mice tested on a motorized treadmill (moving at 8 -10 cm/s) prior to and 15-20 min after drug administration. Comparisons were made between three main groups (D 1/5 -treated group; 5-HT 1A/7 -treated group; D 1/5 ϩ 5-HT 1A/7 -treated group) to clearly determine whether significantly greater effects may be induced by these selective agonists used in combination rather than separately. Preliminary results have been reported in abstract form .
M E T H O D S

Animals and surgery
This work was performed in accordance with the Canadian Guide for the Care and Use of Laboratory Animals. All procedures were approved by the Animal Research Committee of the Laval University Medical Centre. Experiments were carried out on male CD1 mice (n ϭ 40; Charles River Laboratories, Montreal, Quebec) weighing 30 -35 g at the time of surgery. Mice were housed generally four or five per cage in a temperature-controlled environment maintained under a 12-h light/dark cycle with free access to water and food (Teklab global 18% protein rodent diet 2018; Harlan Teklab, Madison, WI). Preoperative care included injections 30 min prior to surgery of lactate-Ringer solution (1.0 ml, administered subcutaneously [sc]), an antibiotic (Baytril; 5 mg/kg, sc; Bayer, Toronto, Ontario), and an analgesic (buprenorphine; 0.1 mg/kg, sc; ScheringPlough, Pointe-Claire, Quebec). The surgery was performed under general anesthesia with isoflurane (2.5%) as described elsewhere (Guertin 2005; Lapointe et al. 2006; Ung et al. 2007 ). Briefly, a nonlaminectomy complete spinal cord transection (Tx) was performed using microscissors inserted between the ninth and tenth thoracic vertebrae. The inner vertebral walls were then entirely scraped with scissor tips to sever any remaining fibers that had not been previously cut. The opened skin area was sutured and animals were placed on heating pads for a few hours. Postoperative care included daily injections of lactate-Ringer solution (2 ϫ 1.0 ml, sc), buprenorphine (2 ϫ 0.1 mg/kg, sc), and Baytril (5 mg/kg, sc) for four consecutive days. Bladders were manually expressed twice a day until testing (at 6 days post-Tx). Full transection was confirmed by postmortem histological analyses (i.e., staining longitudinal or coronal sections with luxol fast blue/cresyl violet). Only animals with a histologically confirmed complete Tx were kept for analyses.
Drug treatments
All treatments were performed at 6 days post-Tx to allow reasonable time for the animals to recover from surgery before behavioral testings. A first group of mice (n ϭ 20) received either 0.25 (n ϭ 5), 0.5 (n ϭ 5), 1.0 (n ϭ 5), or 2.0 mg/kg (n ϭ 5) of 6-chloro-2,3,4,5-tetrahydro-1-phenyl-1H-3-benzazepine hydrobromide (SKF-81297) to establish its threshold for LM induction. Another group of animals (n ϭ 6) was pretreated with SCH 23390 (potent D 1/5 antagonist, 1 mg/kg) 15 min prior to SKF-81297 administration to confirm D 1/5 -mediated effects induced by SKF-81297. The lowest effective dose (0.5 mg/kg) of 8-hydroxy-2-dipropylaminotetralin hydrobromide (8-OH-DPAT, selective 5-HT 1A/7 receptor agonist) was chosen based on recent data from this laboratory (Landry et al. 2006a) . As with SKF-81297, 8-OH-DPAT was also administered separately in a group of Tx mice (n ϭ 9) to characterize in this study its effects at the lowest effective dose. A last group of animals (n ϭ 5) received the combination treatment with the lowest effective doses of SKF-81297 (determined in this study to be 1-2 mg/kg; see Fig. 1 ) and 8-OH-DPAT (0.5 mg/kg; Landry et al. 2006a ). All drugs were administered intraperitoneally and purchased from Tocris (Ellisville, MO). 8-OH-DPAT was diluted in sterile water, whereas SKF-81297 was first dissolved in dimethylsulfoxide (DMSO) and then diluted in sterile water to obtain a solution of 2% (vol/vol) DMSO in water. This dose of DMSO was found not to interfere with locomotor rhythmogenesis (unpublished observations).
Assessment of hindlimb movements
Drug-induced effects were assessed in Tx mice placed on a motorized treadmill moving at 8 -10 cm/s. A harness placed around the torso was used to maintain the animals in front of the camera (placed FIG. 1. Dose-response effects of SKF-81297 at 6 days post-spinal cord-transected (Tx) animals in treadmill condition. Doses of 1.0 and 2.0 mg/kg SKF-81297 induced generally significant increases of nonlocomotor movements (NLMs), locomotor-like movements (LMs), average combined scores (ACOS), and Antri, Orsal, and Barthe (AOB) scores (A-D, respectively), whereas 0.25 and 0.5 mg/kg induced no or slight increases. #P ϭ 0.06 and **P Ͻ 0.01 compared with preinjection. sideways). However, no body weight support assistance or other forms of stimulation (e.g., tail pinching) was provided to minimize variability and avoid unrelated (or unnatural) sensory input-mediated drug-induced effects. Hindlimb movements were monitored using a digital videocamera system (Sony DCR110, acquisition: 30 frames/s, shutter speed: 1/4,000) during 4 min immediately prior to and 15-20 min after drug administration. Two methods designed specifically to assess hindlimb movement in complete Tx rodents were used. The first method called average combined score (ACOS) (Guertin 2005; Lapointe et al. 2006; Ung et al. 2007 ) is a semiquantitative approach developed in this laboratory to assess essentially the frequency (number/min) of nonlocomotor movements (NLMs) and locomotor-like movements (LMs) as well as their amplitude and incidence. In brief, one NLM is defined as a unilateral movement (e.g., fast paw shaking, twitch, cramp, jerk, or any other nonbilaterally coordinated movements), whereas one LM is defined as a flexion followed by an extension (or vice versa) occurring in both hindlimbs in alternation (a bilaterally alternating locomotor-like movement). Movement amplitude was reported as small or large and given the arbitrary numerical value of 1 or 2, respectively. Movement incidence is defined as the number of animals in which NLMs or LMs were observed. ACOS scores were obtained by arithmetically combining these values as follows: (Guertin 2005) . The presence of weight-bearing and plantar foot placement capabilities was also examined and reported separately.
A second assessment method developed by Antri, Orsal, and Barthe (AOB; Antri et al. 2002) was also used. As with the ACOS method, this AOB scale has been specifically designed to assess hindlimb movement induced by CPG-activating compounds in complete paraplegic rodents. Briefly, it is a scale including 22 discriminating scores, mainly grouped into four categories or levels. The first level (scores 0 and 1) reports either the absence of movement or the presence of small amplitude jerks. The second level (scores 2-9) includes rhythmic locomotor-like movements accompanied of dorsal foot placement. The third level (score 10) is associated with the occurrence of large-amplitude locomotor-like movements with dorsal foot placement and occasional body weight support. Finally, the last level (scores 11-22) reports movements accompanied by plantar foot placement and body weight support. For additional details, see Antri et al. (2002) .
Statistical analyses
Paired t-tests were used to compare pre-vs. postinjection data. Comparisons between groups were performed with one-way ANOVAs followed by Tukey's post hoc tests when significant. All analyses were done using SPSS 11.0 (Chicago, IL). Results are expressed as means Ϯ SE. Values of P Ͻ 0.05 were deemed statistically significant.
R E S U L T S
SKF-81297-induced hindlimb movements in Tx mice
A first group of mice (n ϭ 20) received either 0.25, 0.5, 1.0, or 2.0 mg/kg to establish the lowest effective dose of SKF-81297 for inducing LMs. As shown elsewhere (Guertin 2005; Lapointe et al. 2006) and throughout this study, no LMs but occasional NLMs (reflex-induced) were typically found to spontaneously occur with no drug treatment in 1-wk Tx animals (see preinjection conditions; white bars in Fig. 1, A and  B) . We found in this study that administration of SKF-81297 induced within 15 min a dose-dependent increase of NLMs (reported as numbers of NLM/min). Indeed, although essentially no NLM was found in the 0.25 mg/kg-treated group, generally significant (#P ϭ 0.06, although the data were not significant, there was a possibility of a false-negative finding because the power was low, **P Ͻ 0.01) values were obtained in the 1.0 mg/kg-treated (6.30 Ϯ 2.30) and 2.0 mg/kg-treated groups (12.40 Ϯ 1.28), respectively (black bars, Fig. 1A ). Although absolutely no LM was found to spontaneously occur prior to drug administration (Fig. 1B, white bars) , generally significant (#P ϭ 0.06 or **P Ͻ 0.01) numbers of LM were found only at 1.0 mg/kg (4.70 Ϯ 2.27) and 2.0 mg/kg (7.00 Ϯ 0.94) (black bars, Fig. 1B) . Comparable results were obtained using the corresponding ACOS (Ͼ27 at 1.0 mg/kg) and AOB scores (Ͼ4 at 1.0 mg/kg), clearly showing that the lowest effective dose of SKF-81297 for inducing significant hindlimb movements (reported either as NLM, LM, ACOS, or AOB scores) was between 1 and 2 mg/kg. Consequently, we used 1 or 2 mg/kg SKF-81297 (equal number of animals tested with each dose) in each subsequent test.
To confirm whether SKF-81297-induced effects (at 1 and 2 mg/kg) were indeed mediated by the D 1/5 receptors, we administered 1 or 2 mg/kg SKF-81297 in another group of animals (n ϭ 6) pretreated 15 min earlier with a selective D 1/5 receptor antagonist called SCH 23390 (1.0 mg/kg). Figure 2 shows that a significant (P Ͻ 0.001) reduction of LM and NLM was found following administration of SKF-81297 in the SCH 23390 -pretreated group compared with controls. In fact, the relatively low NLM, LM, ACOS, and AOB values and scores found in the SCH 23390 -pretreated group that received SKF-81297 (dark gray bars) were not dissimilar (P Ͼ 0.05) from those found preinjection (Fig. 2, white bars) or just prior to SKF-81297 administration (SCH 23390 only; Fig. 2 , pale gray bars).
8-OH-DPAT-induced hindlimb movements in Tx mice
The lowest effective dose of 8-OH-DPAT (a 5-HT 1A/7 receptor agonist) for inducing LM has been found previously to be Ͻ1.0 mg/kg (Landry et al. 2006a ). In addition, Landry et al. (2006a) clearly established that these effects completely disappeared in animals pretreated with the corresponding receptor antagonists (WAY100135 and SB269970), thus providing strong evidence of 5-HTR 1A -and 5-HTR 7 -mediated effects. Here, we found that 0.5 mg/kg 8-OH-DPAT induced some hindlimb movements that were comparable with those described earlier, elicited by 1 mg/kg SKF-81297. 8-OH-PAT (0.5 mg/kg, ip) generated occasional but significant (P Ͻ 0.05) numbers of LM (3.67 Ϯ 1.44; P Ͻ 0.05) and NLM (9.29 Ϯ 2.73; P Ͻ 0.05; Fig. 3D ). LM and NLM were found in, respectively, 67 and 89% of the treated mice (Fig. 3E , corresponding incidence values). Although only small-amplitude movements were found (Ϯ1, Fig. 3D ), 8-OH-DPAT-induced effects corresponded to a significant increase (P Ͻ 0.05 and P Ͻ 0.01, respectively) of ACOS and AOB scores postinjection versus preinjection (black bars vs. white bars; Fig. 3 , E and F). In turn, no incidence of weight-bearing stepping (WBS) or plantar foot placement (PFP) was found at 0.5 mg/kg in this study (Fig. 3F) or elsewhere with higher doses of 8-OH-DPAT (0.25-2.0 mg/kg; Landry et al. 2006a ). As with 8-OH-DPAT, only small-amplitude movements (Ϯ1) with no WBS and rare PFP placement (i.e., found occasionally in three of nine mice; see Fig. 3C vs. Fig. 3B) were also induced by the lowest effective dose of SKF-81297.
SKF-81297 ϩ 8-OH-DPAT-induced hindlimb movements in Tx mice
A last group of Tx animals (n ϭ 5) received instead a coinjection of selective D 1/5 and 5-HT 1A/7 receptor agonists. As illustrated in Fig. 4 , simultaneous administration of the lowest effective doses of SKF-81297 (1 or 2 mg/kg) and 8-OH-DPAT (0.5 mg/kg) elicited a 7-to a 10-fold increase in hindlimb movement generation. This combination induced significant (P Ͻ 0.01) numbers of LM (37.70 Ϯ 5.01 LM/min) and NLM (8.30 Ϯ 0.78 NLM/min) postinjection versus preinjection (Fig. 4A , black bars vs. white bars, respectively). Both NLM and LM of large amplitude (near 2) were found in all mice tested (incidence of 100%; Fig. 4, A and B) . Correspondingly, the ACOS and AOB scores reached 167.40 Ϯ 19.48 and 15.80 Ϯ 0.80. In clear contrast with the effects obtained using both agonists separately (Figs. 1-3) , this drug combination induced hindlimb movements that were accompanied of frequent-to-regular WBS and occasional-to-frequent PFP (Fig. 4C) .
To further analyze the existence of synergistic effects, we statistically compared the effects induced by SKF-81297, 8-OH-DPAT or the combination. Figure 5A clearly shows that drug-induced NLM (numbers/min) were not significantly different when comparing the three groups (A, SKF-81297-treated; B, 8-OH-DPAT-treated; AϩB, combination treatment). In turn, a significantly greater number of LM (37.70 Ϯ 5.01 LM/min; P Ͻ 0.001) was found in the combinationtreated group (Fig. 5B , AϩB) constituting a 7-to a 10-fold increase compared with the two other groups (Fig. 5B , SKF-81297-treated, 5.85 Ϯ 1.22; and 8-OH-DPAT-treated, 3.67 Ϯ 1.44). Large movement amplitudes were found only with the combination treatment, given that values were significantly (P Ͻ 0.05) greater than those found in the 8-OH-DPATtreated animals (Fig. 5C ). Although incidence values cannot be statistically compared (i.e., no associated SE values), frequent WBS and PFP were found only in the combination-treated mice (see Fig. 4C vs. 3, C and F) . Consequently, the ACOS and AOB scores found in the combination-treated group were also significantly (P Ͻ 0.001) greater (between 4-and 6-fold larger) than those in the other two groups (Fig. 5, D and E) , altogether clearly demonstrating the existence of synergistic effects on CPG-mediated hindlimb movement generation when both types of agonists are used in combination rather than separately.
These effects are best illustrated with video images and angular excursion analyses (using data measured at the hip, knee, and ankle) obtained from a few typical animals. Figure 6A 1 shows that no clear movement was found in this Tx mouse prior to drug administration. A corresponding lack of angular excursion was also reported at the hip, knee, and ankle levels in this control (preinjection) condition (Fig. 6A 2 ) . In turn, SKF-81297 or 8-OH-DPAT administered separately in two different mice induced hindlimb movements with a resemblance more to rhythmic sweeping than to stepping, as shown by the video images (Fig. 6 , B 1 and C 1 , respectively) and the corresponding angular excursion graphs (Fig. 6 , B 2 and C 2 ; clear cyclic variations at the knee and ankle levels but not at the hip). Finally, in another animal that received the combination treatment, the video images show that rather large-amplitude stepping-like movements with some WBS and PFP were induced by the combination treatment (Fig. 6D 1 ) with corresponding angular value changes at all three main articulations of the hindlimb (Fig. 6D 2 ) .
D I S C U S S I O N
The present results are the first to clearly demonstrate that CPG-activating drugs (specifically the drug combination tested in this study) may be powerful enough for full CPG activation and spinal stepping generation (self-sustained weight-bearing and plantar foot placement capabilities) with no other forms of assistance or stimulation in untrained Tx animals.
Indeed, drug-induced stepping movements have been found in other models such as in adult Tx cats and rats, but always accompanied with other forms of stimulation/intervention including regular treadmill training, tail or perineal pinching, and body weight support assistance (e.g., in cats: Barbeau and Rossignol 1991; in rats: Antri et al. 2002 in rats: Antri et al. , 2005 . Another kind of intervention such as fetal neural tissue transplants combined with 5-HT 2 agonists and regular treadmill training have also led to significant locomotor function recovery in young Tx rats (Kim et al. 1999) . There is compelling evidence suggesting that these forms of assistance and stimulation have a significant influence over CPG activation. In fact, regular treadmill training itself has been shown to largely restore reflex stepping in complete Tx cats (in adult cats: Barbeau and Rossignol 1987; Lovely et al. 1986; in kittens: Forssberg et al. 1980 ). Tail pinching has been shown to play a critical role in spinal stepping generation. It is generally performed in most spinal cat studies (including those cited earlier) and was reported in untrained Tx cats to induce full weight-bearing stepping in treadmill condition (de Leon et al. 1998) . Comparable effects were detected occasionally using tail stimulation in Tx mice (Leblond et al. 2003) . Norreel et al. (2003) demonstrated that mechanical stimulation of the tail in spinal cord-transected neonatal rats could trigger episodes of air-stepping, whereas this type of stimulus was ineffective in sham-operated rats. A direct activation of CPG neurons by tail-related inputs is also supported by results from in vitro isolated spinal cords showing locomotor-like rhythms induced by sacrocaudal afferent stimulation (Strauss and Lev-Tov 2003) . Another key factor that can affect CPG activation post spinal cord injury (SCI) is time. It is increasingly recognized that sublesional plasticity events that may affect CPG reorganization and excitability occur spontaneously within a few weeks to a few months post-SCI (e.g., see DISCUSSION in Landry et al. 2006b ). For instance, it was shown without intervention (i.e., no grafts, drugs, training, or tail stimulation) that low but significant levels of hindlimb movements may spontaneously occur in mice within a few weeks post-Tx in open-field or treadmill conditions (Guertin 2005; Lapointe et al. 2006; Ung et al. 2007 ).
This said, it is likely that several types of sensory input have nonetheless contributed to the potent effects reported in this study. For instance, sensory inputs associated with the foot and the rest of the leg rubbing against the running treadmill belt (8 -10 cm/s) could have contributed to spinal stepping induction. This is supported by earlier data from this laboratory showing greater (higher frequency) hindlimb movements (both LM and NLM) following SR57227A (a 5-HT 3 agonist) administration in treadmill condition than in open-field or air-stepping conditions (Guertin and Steuer 2005) . Cycling inputs from the hip joint may also have contributed to entrain cyclic changes and rhythms, as elegantly shown several years ago in Tx cats (Andersson and Grillner 1983; Grillner and Rossignol 1978) . Group I afferent inputs from extensors could also have participated to augment contractions in homonymous and heteronymous extensor muscles during the extension phase (Guertin et al. 1995). Incidence is the number of animals in which NLMs or LMs as well as body weightbearing steps (WBS) and plantar foot placement capability (PFP) was found. *P Ͻ 0.05, **P Ͻ 0.01, and ***P Ͻ 0.001 compared with preinjection.
Mechanistically, compelling evidence indicates that these effects specifically involved an activation of 5-HT 1A , 5-HT 7 , and D 1 receptors. As mentioned earlier, bath-applied 5-HT, DA, and/or NMDA was found to potently induce stable fictive locomotor rhythms in in vitro isolated spinal cord preparations (rats: Cazalets et al. 1992; Kiehn and Kjaerulff 1996; Kjaerulff et al. 1994; mice: Gordon and Whelan 2006; Jiang et al. 1999; Whelan et al. 2000; lampreys: Zhang and Grillner 2000) . A specific role in CPG activation for only a subset of receptors has also been suggested by data from in vitro experiments. For example, selective D 1-like (D 1 and D 5 ) agonists (but not D 2-like agonists) were found to produce effects (inducing or modulating) comparable to those found with DA on spinal rhythms in rat isolated spinal cord preparations (Barrière et al. 2004) . 5-HT 1A receptor agonists (but not 5-HT 2 agonists) were also reported to reversibly (blocked by corresponding antagonists) elicit rhythms and cellular effects comparable to those found with 5-HT in the lamprey spinal cord model (Wikstrom et al. 1995; Zhang and Grillner 2000) . Evidence suggesting a role in spinal rhythm generation for other receptor subtypes such as the 5-HT 2A and 5-HT 7 has also been reported (Liu and Jordan 2005; Madriaga et al. 2004 (Lapointe and Guertin 2005; unpublished data) . We have also recently found that 8-OH-DPAT-induced LMs in spinal Tx mice were completely blocked only after coadministration of selective 5-HT 1A and 5-HT 7 antagonists or in 5-HT 7 Ϫ/Ϫ pretreated with 5-HT 1A antagonists, clearly suggesting that 8-OH-DPAT-induced locomotor-like movements critically depend on both receptor subtypes (i.e., 5-HT 1A and 5-HT 7 ; Landry et al. 2006a) . It is worth mentioning that none of these experiments with 8-OH-DPAT or SKF-81297 used separately revealed self-sustained weight-bearing stepping (Landry et al. 2006a; Lapointe and Guertin 2005) . Instead, prior to the present study, only some locomotor-like movements without weight-bearing or plantar foot placement capabilities (resembling crawling more than stepping) had been FIG. 4. Effects of the combination treatment on hindlimb movement generation in treadmill condition. Significant induction of NLMs, LMs, ACOS, and AOB scores (A-C, respectively) following the administration of both agonists in early Tx mice. Incidence is number of animals in which NLMs or LMs as well as WBS and PFP was found. **P Ͻ 0.01 and ***P Ͻ 0.001 compared with preinjection. WBS occasional : n ϭ 1; WBS frequent : n ϭ 3; WBS consistent : n ϭ 3 and PFP occasional : n ϭ 1; PFP frequent : n ϭ 4. found with these ligands as well as with a number of others compounds administered separately or in combination [i.e., 5-HT 3 agonists used separately or combined with 5-HT 7 agonists (Guertin and Steuer 2005) ; L-DOPA alone or combined with 5-HT 2A/2C agonists (Guertin 2004a) ; 5-HT 2A/2C agonists alone or combined with NMDA (Guertin 2004b) ; 5-HT 1B/2B/2C agonists used separately or combined with L-DOPA (Landry and Guertin 2004) ].
In conclusion, this study reveals that 1-2 mg/kg SKF-81297 and 0.5 mg/kg 8-OH-DPAT administered separately can trigger some NLMs and LMs with no weight-bearing or plantar foot placement capabilities in spinal cord-transected mice. The main finding is that when combined using the same doses, these ligands can induce a 7-to 10-fold increase in LM generation (37.70 Ϯ 5.01 LM/min) accompanied by significant weight-bearing and plantar foot placement. These synergistic effects were found in early paraplegic animals without other forms of assistance or stimulation (untrained, no tail pinching, no grafts, etc.), strongly suggesting the existence of CPGmediated actions. Together with earlier work from our laboratory using selective antagonists and knockout animals (5-HT 7
Ϫ/Ϫ and D 5 Ϫ/Ϫ ), the present finding strongly suggests the existence of a critical role for the 5-HT 1A , 5-HT 7 , and D 1 receptors in CPG activation and hindlimb stepping generation in vivo. This may pave the way to the development of novel pharmacological treatments aimed at promoting treadmill training in SCI patients. 
